Literature DB >> 18039925

Chronic kidney disease after nonrenal solid-organ transplantation.

Roy D Bloom1, Peter P Reese.   

Abstract

Chronic kidney disease (CKD) is a common complication after nonrenal solid-organ transplantation. The risk for CKD is influenced by many factors, some of which have a direct impact on how such patients are treated in the pre-, peri-, and posttransplantation settings. This review describes hazards for acute and chronic kidney injury, with particular emphasis on calcineurin inhibitor-mediated nephrotoxicity. Rather than a detailed description of management issues that are common to the general CKD population, highlighted are aspects that are more specific to nonrenal solid-organ transplant recipients with a focus on liver, heart, and lung recipients. Strategies to minimize nephrotoxic insults and retard progressive renal injury are discussed, as are issues that are pertinent to dialysis and transplantation. Finally, future approaches to prevent and treat CKD without compromising function of the transplanted organ are addressed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18039925     DOI: 10.1681/ASN.2007040394

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

1.  Adoptive T cell therapy for the treatment of viral infections.

Authors:  Reuben J Arasaratnam; Ann M Leen
Journal:  Ann Transl Med       Date:  2015-10

2.  Renal transplantation outcomes following heart and heart-lung transplantation.

Authors:  L Wong; Y R Chee; D G Healy; J J Egan; D M Sadlier; Y M O'Meara
Journal:  Ir J Med Sci       Date:  2016-12-31       Impact factor: 1.568

3.  Comparison of survival of patients with heart and lung transplants on peritoneal dialysis and hemodialysis.

Authors:  Pramod Guru; Rachita Prakash; Heena Sheth; Filitsa Bender; Renee Burr; Beth Piraino
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

4.  [Modern immunosuppression after solid organ transplantation].

Authors:  J Beimler; C Morath; M Zeier
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

5.  Evaluation and Management of CKD in the Nonkidney Solid Organ Transplant Recipient.

Authors:  Karen M Warburton; Alden M Doyle
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-11       Impact factor: 8.237

6.  Underestimation of chronic renal dysfunction after liver transplantation: ICEBERG study.

Authors:  Evaristo Varo; Rafael Bañares; Magda Guilera
Journal:  World J Transplant       Date:  2015-03-24

7.  Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015?

Authors:  Lajos Zsom; László Wagner; Tibor Fülöp
Journal:  World J Transplant       Date:  2015-09-24

8.  Recipient survival and graft survival are not diminished by simultaneous liver-kidney transplantation: an analysis of the united network for organ sharing database.

Authors:  Eric F Martin; Jonathan Huang; Qun Xiang; John P Klein; Jasmohan Bajaj; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

9.  Utilization of an EMR-biorepository to identify the genetic predictors of calcineurin-inhibitor toxicity in heart transplant recipients.

Authors:  Matthew Oetjens; William S Bush; Kelly A Birdwell; Holli H Dilks; Erica A Bowton; Joshua C Denny; Russell A Wilke; Dan M Roden; Dana C Crawford
Journal:  Pac Symp Biocomput       Date:  2014

Review 10.  Metabolic consequences of modern immunosuppressive agents in solid organ transplantation.

Authors:  Oluwatoyin Bamgbola
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-30       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.